Intel (NASDAQ: INTC), Complete Genomics (NASDAQ: GNOM), Genuine Parts Company (NYSE: GPC), Goldman Sachs (NYSE: GS), Home Properties (NYSE: HME) and Hospira, Inc. (NYSE: HSP) had price targets on them adjusted by analysts.
Intel (INTC) had its price target raised by Goldman Sachs (NYSE:GS) to $22.00.
Complete Genomics (GNOM) had its price target lowered by UBS AG (NYSE:UBS) from $8.50 to $6.00. They have a “Neutral” rating on the company.
Genuine Parts Company (GPC) had its price target raised by JPMorgan Chase & Co. (NYSE:JPM) to $62.00.
Goldman Sachs (GS) had its price target lowered by Barclays Capital from $150.00 to $145.00. They have an “Equal Weight” rating on the company.
Home Properties (HME) had its price target lowered by Barclays Capital from $66.00 to $60.00. They have an “Equal Weight” rating on the company.
Hospira, Inc. (HSP) had its price target lowered by Barclays Capital from $44.00 to $30.00. They have an “Underweight” rating on the company.
Thursday, October 20, 2011
Intel (INTC) (GNOM) (GPC) (GS) (HME) (HSP) Price Targets Changed
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment